Search

Quest Diagnostics Inc

Slēgts

SektorsVeselības aprūpe

235.5 0.06

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

232

Max

236.07

Galvenie mērījumi

By Trading Economics

Ienākumi

70M

334M

Pārdošana

148M

3B

P/E

Sektora vidējais

25.201

56.597

EPS

3.12

Dividenžu ienesīgums

1.39

Peļņas marža

10.976

Darbinieki

46,000

EBITDA

47M

481M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+7.86% upside

Dividendes

By Acuity

Dividenžu ienesīgums

Sektora vidējais

1.39%

2.18%

Nākamie ieņēmumi

2026. g. 20. okt.

Nākamais dividenžu datums

2026. g. 21. okt.

Nākamais Ex dividenžu datums

2026. g. 6. okt.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

3.2B

26B

Iepriekšējā atvēršanas cena

235.44

Iepriekšējā slēgšanas cena

235.5

Ziņu noskaņojums

By Acuity

15%

85%

12 / 339 Rangs Healthcare

Quest Diagnostics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 9. sept. 21:01 UTC

News

Quest Diagnostics shares are lower after announcing a new lab test panel for Apple Health app users, priced at $119.

2026. g. 8. sept. 23:26 UTC

Quest Diagnostics Inc shares are higher in after-market hours, reaching a peak cumulative return of 0.78%. No specific news was identified to explain this movement.

2026. g. 4. sept. 19:36 UTC

Quest Diagnostics shares are lower amid rising Treasury yields and expectations of tighter monetary policy from the Federal Reserve. The stock is below its 20-day moving average.

2026. g. 3. sept. 21:04 UTC

Quest Diagnostics Inc shares are higher in after-market trading, showing notable strength during the session. No specific news was identified to explain the movement.

2026. g. 2. sept. 20:03 UTC

News

Quest Diagnostics has signed a multi-year agreement with Renalytix PLC for kidney testing, contributing to shares trading higher during Wednesday's session.

2026. g. 1. sept. 23:36 UTC

News

Quest Diagnostics has signed a multi-year agreement with Renalytix PLC for kidneyintelX.dkd testing, contributing to a modest rise in shares during after-market hours.

2026. g. 31. aug. 23:26 UTC

Quest Diagnostics Inc is rising in after-market trading, rebounding from three days of declines. Broader market dynamics may be influencing investor sentiment.

2026. g. 28. aug. 19:46 UTC

Quest Diagnostics Inc shares are lower today, continuing a decline since Thursday. Broader market conditions and inflation concerns may be influencing the price action.

2026. g. 27. aug. 23:06 UTC

Quest Diagnostics shares are trading lower in after-market hours. The decline follows three consecutive sessions of gains amid mixed market sentiment.

2026. g. 26. aug. 19:46 UTC

Quest Diagnostics shares are lower today, reflecting broader market trends amid rising consumer prices, as indicated by the recent PCE price index data.

2026. g. 25. aug. 23:42 UTC

Correlated Moves

Quest Diagnostics Inc shares declined in after-market trading, following a similar trend seen in Labcorp Holdings Inc. The stock moved lower since Tuesday's close.

2026. g. 24. aug. 23:36 UTC

Event

Quest Diagnostics announced developments in its Alzheimer’s testing portfolio, with shares trading lower in after-market hours amid broader market volatility.

2026. g. 21. aug. 23:01 UTC

Quest Diagnostics shares declined in after-market trading, despite remaining above their 20-day moving average and near the upper end of their one-month range.

2026. g. 20. aug. 20:01 UTC

Quest Diagnostics Inc is trading higher, continuing its upward trend since Wednesday. The stock reached a session high earlier before pulling back slightly.

2026. g. 19. aug. 23:56 UTC

Quest Diagnostics Inc shares are higher in after-market hours, continuing a trend of four consecutive sessions finishing above their 20-day moving average.

2026. g. 17. aug. 19:46 UTC

Correlated Moves
News

Quest Diagnostics Inc's shares are higher, supported by Zacks Research raising Q3 EPS estimates to $2.82 from $2.79 following strong Q2 results.

2026. g. 12. aug. 19:46 UTC

Quest Diagnostics shares are higher, reflecting broader market gains from positive inflation sentiment. The stock remains above its 20-day moving average.

2026. g. 11. aug. 19:26 UTC

Quest Diagnostics shares are higher today, reflecting a general upward trend since Monday. Investors await upcoming U.S. inflation reports that may impact market sentiment.

2026. g. 10. aug. 23:36 UTC

Quest Diagnostics Inc shares are trading higher in after-market hours, showing notable upward movement despite no specific company news identified.

2026. g. 7. aug. 21:01 UTC

Quest Diagnostics Inc. shares are higher in after-market trading, reflecting strong performance above the 20-day moving average and near the one-month range's upper end.

2026. g. 6. aug. 23:01 UTC

Quest Diagnostics Inc. shares declined in after-market trading, reversing a three-session upward trend. The stock remains above its 20-day moving average.

2026. g. 5. aug. 19:36 UTC

Quest Diagnostics Inc shares are higher amid positive market sentiment and easing inflation concerns related to falling crude oil prices. The stock is near its one-month high.

2026. g. 4. aug. 22:02 UTC

Quest Diagnostics Inc shares declined in after-market trading, despite broader positive market sentiment. No specific news was identified to explain the drop.

2026. g. 3. aug. 19:46 UTC

Quest Diagnostics Inc. shares are lower today, continuing a trend of declines after four consecutive sessions of lower closes. No specific news has been identified.

2026. g. 31. jūl. 20:04 UTC

Correlated Moves

Quest Diagnostics is lower today, reflecting broader declines in the Health Care Services sector, including a drop in Labcorp Holdings.

2026. g. 30. jūl. 23:02 UTC

Quest Diagnostics shares are higher in after-market trading, recovering from an earlier dip. The price remains above its 20-day moving average.

2026. g. 29. jūl. 20:08 UTC

Correlated Moves

Quest Diagnostics shares are lower amid a broader decline in the Health Care Services sub-sector, reflecting a negative trend seen since Tuesday's close.

2026. g. 28. jūl. 23:01 UTC

Quest Diagnostics Inc shares are higher in after-market trading, maintaining upward momentum amid broader market strength and trading above their 20-day moving average.

2026. g. 27. jūl. 17:26 UTC

News

Quest Diagnostics Inc. shares are higher today, supported by a 10% revenue increase to $3 billion for Q2 and an improved full-year outlook.

2026. g. 24. jūl. 21:21 UTC

Quest Diagnostics Inc shares are higher in after-market hours, continuing a trend of gains over the past three sessions. No specific news was identified.

Salīdzinājums

Cenas izmaiņa

Quest Diagnostics Inc Prognoze

Cenas mērķis

By TipRanks

7.86% augšup

Prognoze 12 mēnešiem

Vidējais 254 USD  7.86%

Augstākais 265 USD

Zemākais 245 USD

Pamatojoties uz 11 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Quest Diagnostics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

11 ratings

7

Pirkt

4

Turēt

0

Pārdot

Noskaņojums

By Acuity

12 / 339 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Quest Diagnostics Inc

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
help-icon Live chat